MedTrace Logo

Probiotics as Adjuvant Therapy in the Management of Irritable Bowel Syndrome

NCT05523427 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-01-18

No results posted yet for this study

Summary

Studying the effects of adding probiotics to the drug regimen of patients with diarrhea predominant IBS

Conditions

  • Irritable Bowel Syndrome
  • Irritable Bowel Syndrome With Diarrhea

Interventions

DIETARY_SUPPLEMENT

Two probiotic strains (L. plantarum and L. acidophilus)

A capsule containing the L. plantarum and L. acidophilus strains is to be administered twice daily for three months in addition to the standard treatment of IBS.

Sponsors & Collaborators

  • University of Mosul

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-19
Primary Completion
2022-12-21
Completion
2023-01-06

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05523427 on ClinicalTrials.gov